(Q40590020)

21 September 2017

1 reference

title

Autoimmune hepatitis. Evolving concepts and treatment strategies (English)

1 reference

21 September 2017

A J Czaja

1

1 reference

21 September 2017

1 February 1995

1 reference

Digestive Diseases and Sciences

21 September 2017

1 reference

21 September 2017

40

1 reference

21 September 2017

2

1 reference

21 September 2017

435-456

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02065434

21 September 2017

0 references

cites work

Chronic active hepatitis: the challenge for a new nomenclature

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Hepatitis C virus infection in patients with nonalcoholic chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02065434

Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal

21 January 2018

1 reference

12 December 2020

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis

1 reference

12 December 2020

Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH)

1 reference

12 December 2020

Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

1 reference

12 December 2020

Hepatitis C virus replication in 'autoimmune' chronic hepatitis

1 reference

12 December 2020

Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis

1 reference

12 December 2020

Cyclosporine immunosuppression

1 reference

12 December 2020

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Arginine Thiazolidinecarboxylate in the Treatment of Chronic Active Hepatitis: Double-Blind Comparison with Placebo

1 reference

12 December 2020

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

12 December 2020

Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology

1 reference

12 December 2020

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

12 December 2020

Autoimmune chronic active hepatitis masquerading as acute hepatitis

1 reference

12 December 2020

Subdivisions of idiopathic autoimmune chronic active hepatitis

1 reference

12 December 2020

Type II autoimmune hepatitis. What is the role of the hepatitis C virus?

1 reference

12 December 2020

Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis

1 reference

12 December 2020

Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis

1 reference

12 December 2020

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

12 December 2020

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

12 December 2020

High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis

1 reference

12 December 2020

FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh

1 reference

12 December 2020

Case against subclassification of type II autoimmune chronic active hepatitis

1 reference

12 December 2020

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

1 reference

12 December 2020

Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity

1 reference

12 December 2020

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

12 December 2020

Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders

1 reference

12 December 2020

Is autoimmune chronic active hepatitis a HCV-related disease?

1 reference

12 December 2020

Ageing and autoantibodies

1 reference

12 December 2020

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

1 reference

12 December 2020

Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis

1 reference

12 December 2020

The cellular infiltrate in the liver in auto-immune chronic active hepatitis: analysis with monoclonal antibodies

1 reference

12 December 2020

'Acute' autoimmune hepatitis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis

1 reference

12 December 2020

Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection

1 reference

12 December 2020

1 reference

12 December 2020

Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis

1 reference

12 December 2020

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

1 reference

12 December 2020

Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial

1 reference

12 December 2020

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

1 reference

12 December 2020

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

1 reference

12 December 2020

Hepatitis C virus antibodies among risk groups in Spain

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis

1 reference

12 December 2020

An immunogenetic study of suppressor cell activity in autoimmune chronic active hepatitis

1 reference

12 December 2020

Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis

1 reference

12 December 2020

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

12 December 2020

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

12 December 2020

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

1 reference

12 December 2020

The significance of natural autoantibodies

1 reference

12 December 2020

Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses

1 reference

12 December 2020

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

1 reference

12 December 2020

Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial

1 reference

12 December 2020

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

12 December 2020

Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis

1 reference

12 December 2020

Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology

1 reference

12 December 2020

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study

1 reference

12 December 2020

Autoimmune chronic active hepatitis developing after acute type B hepatitis

1 reference

12 December 2020

Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces

1 reference

12 December 2020

Cyclosporine treatment of autoimmune chronic active hepatitis

1 reference

12 December 2020

Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.

1 reference

12 December 2020

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

12 December 2020

Persistent measles virus genome in autoimmune chronic active hepatitis

1 reference

12 December 2020

Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

1 reference

12 December 2020

Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role

1 reference

12 December 2020

Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis

1 reference

12 December 2020

Smooth muscle autoantibodies and autoantigens

1 reference

12 December 2020

Anti-GOR and hepatitis C virus in autoimmune liver diseases

1 reference

12 December 2020

M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?

1 reference

12 December 2020

Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies

1 reference

12 December 2020

Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy

1 reference

12 December 2020

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

1 reference

12 December 2020

Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans

1 reference

12 December 2020

Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences

1 reference

12 December 2020

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

1 reference

12 December 2020

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

12 December 2020

HLA Determinants in Chronic Active Liver Disease: Possible Relation of HLA-Dw3 to Prognosis

1 reference

12 December 2020

Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo

1 reference

12 December 2020

Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis

1 reference

12 December 2020

How many types of autoimmune hepatitis are there?

1 reference

12 December 2020

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

12 December 2020

T-cell function in aging: mechanisms of decline

1 reference

12 December 2020

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

12 December 2020

Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.

1 reference

12 December 2020

The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat

1 reference

12 December 2020

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment

1 reference

12 December 2020

Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies

1 reference

12 December 2020

Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.

1 reference

12 December 2020

Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis

1 reference

12 December 2020

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

1 reference

12 December 2020

Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses

1 reference

12 December 2020

Effect of polyunsaturated phosphatidylcholine on immune mediated hepatocyte damage

1 reference

12 December 2020

Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study

1 reference

12 December 2020

The asialoglycoprotein receptor as target structure in autoimmune liver diseases

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

1 reference

12 December 2020

Interferon-induced chronic active hepatitis?

1 reference

12 December 2020

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

1 reference

12 December 2020

Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis

1 reference

12 December 2020

Autoimmune hepatitis and viral infection.

1 reference

12 December 2020

Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment

1 reference

12 December 2020

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

12 December 2020

Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes

1 reference

12 December 2020

FK 506 and rapamycin: molecular probes of T-lymphocyte activation

1 reference

12 December 2020

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.

1 reference

12 December 2020

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States

1 reference

12 December 2020

Antigen specific suppressor cell function in autoimmune chronic active hepatitis

1 reference

12 December 2020

Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

1 reference

12 December 2020

Immunological Aspects of Chronic Active Hepatitis

1 reference

12 December 2020

Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?

1 reference

12 December 2020

Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting

1 reference

12 December 2020

In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis

1 reference

12 December 2020

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

1 reference

12 December 2020

Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus

1 reference

12 December 2020

Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis.

1 reference

12 December 2020

Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis

1 reference

12 December 2020

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

1 reference

12 December 2020

The problem of chronic liver disease in young women

1 reference

12 December 2020

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

12 December 2020

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

12 December 2020

DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects

1 reference

12 December 2020

Disordered immunoregulatory functions in patients with chronic active hepatitis

1 reference

12 December 2020

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

1 reference

12 December 2020

Current problems in the diagnosis and management of chronic active hepatitis

1 reference

12 December 2020

Human immunodeficiency virus infection mimics autoimmune hepatitis--a case report

1 reference

12 December 2020

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

12 December 2020

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

1 reference

12 December 2020

Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat.

1 reference

12 December 2020

Immune mechanisms in autoimmune chronic active hepatitis.

1 reference

12 December 2020

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

12 December 2020

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

12 December 2020

Auto-immune chronic active hepatitis: a specific entity? The negative argument

1 reference

12 December 2020

Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.

1 reference

12 December 2020

1 reference

12 December 2020

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

12 December 2020

HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies

1 reference

12 December 2020

HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

12 December 2020

Immunoregulatory T-cell function in acute and chronic liver disease

1 reference

12 December 2020

Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis

1 reference

12 December 2020

Lymphocyte suppressor cell activity in acute and chronic liver disease

1 reference

12 December 2020

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

12 December 2020

An Analysis of the Composition of the Inflammatory Infiltrate in Autoimmune and Hepatitis B Virus-Induced Chronic Liver Disease

1 reference

12 December 2020

Association of autoimmune active chronic hepatitis with HL-A1,8.

1 reference

12 December 2020

Immunology of chronic active hepatitis

1 reference

12 December 2020

Anti-neutrophil cytoplasmic antibodies in ulcerative colitis

1 reference

12 December 2020

Increased Frequency of HLA-DRW4 in Chronic Active Hepatitis

1 reference

12 December 2020

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

12 December 2020

Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response

1 reference

12 December 2020

Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

12 December 2020

Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance

1 reference

12 December 2020

Natural history, clinical features, and treatment of autoimmune hepatitis

1 reference

12 December 2020

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

12 December 2020

Alteration in suppressor cell activity in chronic active hepatitis

1 reference

12 December 2020

Cyclosporin, a new treatment for autoimmune chronic active hepatitis

1 reference

12 December 2020

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02065434

1 reference

21 September 2017

1 reference

PubMed ID

7851212